Documentos de Zhou D. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Objetivos de Desarrollo Sostenible: "ODS 10: Reducción de las desigualdades"

Subtipo de publicación

Publisher

Nature Structural and Molecular Biology(1)

Theranostics(1)

Área temáticas

Microorganismos, hongos y algas(3)

Área de conocimiento

Inmunología(3)

Biotecnología(2)

Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar(3)

ODS 9: Industria, innovación e infraestructura(2)

ODS 17: Alianzas para lograr los objetivos(1)

Año de Publicación

Origen

Palabras Claves

Antibody cocktail(1)

Antibody-antigen complex(1)

Human monoclonal antibody(1)

In vitro and in vivo function(1)

Receptor-binding domain epitope(1)

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Abstract: Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therap

Palabras claves:

coronavirus, SARS-CoV-2, anti-RBD antibody, receptor binding domain, antibody, immune responses, virus structure

Bailey A.L., Bertram F.K.R., Bolton J., Carroll M.W., Case J.B., Chen R.E., Clare D.K., Dejnirattisai W., Diamond M.S., Dold C., Dong T., Duyvesteyn H.M.E., Fry E.E., Fyfe A., Ginn H.M., Gupta S., Hall D.R., Howe A., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Kafai N.M., Klenerman P., Knight J.C., Knight M.L., Levin R., Liu C., López-Camacho C., Mentzer A.J., Mongkolsapaya J., Paesen G.C., Paterson N.G., Peng Y., Pollard A.J., Radecke J., Ren J., Screaton G.R., Siebert C.A., Skelly D.T., Slon-Campos J., Song Y., Stuart D.I., Supasa P., Tan T.K., Temperton N.J., Thompson C., Townsend A.R., Walter T.S., Wang B., Williams M.A., Ying B., Zhao Y., Zhou D.

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

Abstract: Background: Administration of potent anti-receptor-binding domain (RBD) monoclonal antibodies has be

Palabras claves:

Antibody cocktail, Antibody-antigen complex, Human monoclonal antibody, In vitro and in vivo function, Receptor-binding domain epitope, SARS-COV-2

Buttigieg K.R., Carroll M.W., Charlton S., Chen C., Chen C.P., Chen X., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Ginn H.M., Harding A.C., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Lien C.E., Lin M.Y., Lin T.Y., Ma C., Qin L., Ren J., Rijal P., Schimanski L., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Abstract: The SARS-CoV-2 virus is more transmissible than previous coronaviruses and causes a more serious ill

Palabras claves:

Buttigieg K.R., Carrique L., Carroll M.W., Clare D.K., Coombes N., Dumoux M., Duyvesteyn H.M.E., Elmore M.J., Harrison P.J., Huo J., James W.S., Javier Gilbert Jaramillo, Knight M.L., Le Bas A., Malinauskas T., Mikolajek H., Moynié L., Naismith J.H., Owens R.J., Radecke J., Ren J., Rijal P., Ruza R.R., Shah P.N.M., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Vogirala V.K., Ward P.N., Weckener M., Zhao Y., Zhou D.